Suven Pharmaceuticals (SUVENPHAR.NSE) Q2 2025 Earnings

May 28Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
2.12
2.58
3.04
3.5

Details

Expected EPS
3.3972317261200002
Actual EPS
3.4971503063000005
Surprise EPS
0.1
Surprise Percent
+2.94%

Description

⁨Suven Pharmaceuticals⁩ (⁦SUVENPHAR.NSE⁩) has reported earnings of ⁦3.4971503063000005⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts